de Ruiter BM, van Hattum JW, Lipman D, de Reijke TM, et al. Phase 1 Study of Chemoradiotherapy Combined with Nivolumab +/- Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer. Eur Urol 2022 Aug 3. pii: S0302-2838(22)02522.
PMID: 35933242